Autopsy report · NCT03729284
A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta
Cause of deathFunding or business
“This study has been cancelled prior to FSFV due to business reasons”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Healthy
- Interventions
- Cymbalta Capsules; Duloxetine Hydrochloride Capsules
- Participants
- 0
Trials that died the same way
- Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
“This study has been cancelled due to business reasons” - Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer
“The study was terminated due to futility and lack of future funding” - A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
“The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.” - A Randomized Controlled Trial of Three Vasectomy Techniques
“FHI 360 participation in the study was terminated due to lack of funding” - Therapeutic Exercise in Patients With Hemophilia
“The Study was terminated due to lack of funding for continuing”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.